Basic info
Industry
biotechnology research
Sectors
Biotechnology
Drug Repurposing
Patient-optimised Drug Identification and Analytics
Therapeutics
Genetics
AI-driven Drug-Disease Associations
High-throughput in vivo drug validation
Pharmaceutical
Drug Development
Transgenesis
Date founded
2016
Funding rounds raised
Total raised
$56K
from 1 investors over 1 rounds
G
Genome Biologics raised $56K on June 1, 2017
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)